Raia Drogasil (OTCMKTS:RADLY) Trading Down 6.3% – Should You Sell?

Raia Drogasil S.A. (OTCMKTS:RADLY) was down 6.3% on Thursday . The company traded as low as $3.44 and last traded at $3.44. 19,996 shares were traded during trading, a decline of 73% from the average daily volume of 73,955 shares. The stock had previously closed at $3.67.

Raia Drogasil Stock Down 6.5%

The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41. The business has a 50 day simple moving average of $3.70 and a 200-day simple moving average of $3.94. The firm has a market capitalization of $4.51 billion and a price-to-earnings ratio of 68.60.

Raia Drogasil (OTCMKTS:RADLY) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. Raia Drogasil had a net margin of 2.97% and a return on equity of 18.20%. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. On average, equities analysts expect that Raia Drogasil S.A. will post 0.17 EPS for the current year.

About Raia Drogasil

Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.

The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.

RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century.